Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.
Medical Genome Center, National Center of Neurology and Psychiatry, Kodaira, Japan.
J Transl Med. 2022 Nov 8;20(1):517. doi: 10.1186/s12967-022-03743-7.
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant muscular disorder characterized by asymmetric muscle wasting and weakness. FSHD can be subdivided into two types: FSHD1, caused by contraction of the D4Z4 repeat on chromosome 4q35, and FSHD2, caused by mild contraction of the D4Z4 repeat plus aberrant hypomethylation mediated by genetic variants in SMCHD1, DNMT3B, or LRIF1. Genetic diagnosis of FSHD is challenging because of the complex procedures required.
We applied Nanopore CRISPR/Cas9-targeted resequencing for the diagnosis of FSHD by simultaneous detection of D4Z4 repeat length and methylation status at nucleotide level in genetically-confirmed and suspected patients.
We found significant hypomethylation of contracted 4q-D4Z4 repeats in FSHD1, and both 4q- and 10q-D4Z4 repeats in FSHD2. We also found that the hypomethylation in the contracted D4Z4 in FSHD1 is moderately correlated with patient phenotypes.
Our method contributes to the development for the diagnosis of FSHD using Nanopore long-read sequencing. This finding might give insight into the mechanisms by which repeat contraction causes disease pathogenesis.
面肩肱型肌营养不良症(FSHD)是一种常染色体显性遗传性肌肉疾病,其特征为肌肉不对称性萎缩和无力。FSHD 可分为两种类型:FSHD1 由 4 号染色体 q35 上的 D4Z4 重复收缩引起,FSHD2 由 D4Z4 重复轻度收缩以及由 SMCHD1、DNMT3B 或 LRIF1 中的遗传变异介导的异常低甲基化引起。由于需要复杂的程序,FSHD 的遗传诊断具有挑战性。
我们应用 Nanopore CRISPR/Cas9 靶向重测序通过同时检测核苷酸水平上的 D4Z4 重复长度和甲基化状态,对经基因确认和疑似的患者进行 FSHD 的诊断。
我们发现 FSHD1 中的收缩 4q-D4Z4 重复存在明显的低甲基化,而 FSHD2 中则存在 4q 和 10q-D4Z4 重复的低甲基化。我们还发现,FSHD1 中收缩 D4Z4 的低甲基化与患者表型中度相关。
我们的方法有助于使用 Nanopore 长读测序进行 FSHD 的诊断。这一发现可能深入了解重复收缩导致疾病发病机制的机制。